Hornig/Lipkin cytokine study out now - press release

Messages
2,051
Likes
10,097
Great timing whilst the IOM thing is still in the news!
Michael Sharpe, a professor of psychological medicine, at Britain's Oxford University said the finding was "potentially interesting" but added: "This type of study (a case-control study) is notorious for producing findings that other researchers subsequently fail to replicate."
Or: "Release the hounds, Smithers"
 
Messages
213
Likes
712
Some thoughts:
- Interesting that they found lower cytokines in longer duration patients than in controls. When the preliminary data was first reported awhile ago, I thought they said that controls and longer duration patients had similar levels.
- Why isn't C-Reactive Protein and/or sed rate elevated in short-duration patients if they have so much cytokine inflammation? Makes me wonder if maybe these two tests don't measure inflammation as effectively as has traditionally been thought.
- Some interesting tie-ins (ties-in?) to B cell maturation, which might support the autoimmune theory being explored in Norway and the UK.
 

Simon

Senior Member
Messages
3,789
Likes
14,829
Location
Monmouth, UK
Planning to geek my way through the paper, but will drop at some point.

Sorry, we did try to have separate threads for the paper itself and news discussion but they got merged. So you'll have to put up with my tedious detail here.

General linear model (GLM) and t-test follow-up comparison of all ME/CFS cases (short and long duration combined, n = 298) with controls (n = 348) yielded few significant results, with cases showing lower levels for most analytes
So this is a surprise: not much difference between cases and controls. There was a pattern of slightlly higher levels in patients than controls, but not much to shout about.

By contrast, the same statistical approach showed many significant differences between short and long duration patients, which is the key new finding of this study.
 

Sushi

Moderation Resource Albuquerque
Messages
19,873
Likes
34,892
Location
Albuquerque
This says more than words.
It is interesting that in all but a few of the markers the long term patients were lower than the controls. They mentioned avenues for early intervention when cytokines were high--what about the "after 3 year" group? Anyone see anything from them suggesting avenues of treatment?

Sushi
 

A.B.

Senior Member
Messages
3,780
Likes
23,086
It is interesting that in all but a few of the markers the long term patients were lower than the controls. They mentioned avenues for early intervention when cytokines were high--what about the "after 3 year" group? Anyone see anything from them suggesting avenues of treatment?

Sushi
They measured 51 cytokines, but figure 1 only shows 24. I'm guessing they're only showing the ones that are interesting.
 

Simon

Senior Member
Messages
3,789
Likes
14,829
Location
Monmouth, UK
They also found different patterns between short and long duration patients

early ME/CFS cases had a prominent activation of both pro- and anti-inflammatory cytokines as well as a dissociation of characteristic intercytokine regulatory networks
Long duration patients were much like controls, with similar 'cytokine networks', and cytokines that were up in short duration patients were often down in long duration patients.
 

adreno

PR activist
Messages
4,841
Likes
10,951
So this is a surprise: not much difference between cases and controls. There was a pattern of slightlly higher levels in patients than controls, but not much to shout about.
Not really a surprise, as the short duration (high cytokines) and long duration (low cytokines) cancel each other out when combined.

So between-group differences were small, whereas within-group differences were significant.
 
Last edited: